Ebbie Kalan

Ebbie Kalan is an Assistant Professor in the Department of Behavioral and Community Health at the University of Maryland. His research focuses on addressing health disparities in tobacco product use, designing evidence-based public health policies, and evaluating health communication strategies to reduce non-communicable diseases globally. Key areas include cannabis use, nicotine addiction, and tobacco control among marginalized populations such as people of color, LGBTQ+ communities, and individuals with mental health conditions.

Dr. Kalan employs interdisciplinary methods, combining clinical investigations with epidemiological analyses to advance public health outcomes. His recent work examines the epidemiology of e-cigarette and cannabis use, disparities in tobacco-related health outcomes, and the impact of policy interventions on vulnerable groups. He has contributed to studies on waterpipe smoking trends, the relationship between tobacco use and chronic diseases, and the intersection of acculturation and immunization rates among immigrant populations.

His research also addresses emerging issues like mobile vape retail expansion, the role of graphic health warnings in reducing ENDS use, and the longitudinal effects of nicotine dependence among youth. While no awards are explicitly listed, his contributions align with global health priorities outlined in the Global Burden of Disease Study.

Dr. Kalan’s work is supported by collaborations with federal agencies (e.g., FDA) and large-scale datasets such as the Population Assessment of Tobacco and Health (PATH) Study. He is actively engaged in translating research findings into actionable policies to improve population health equity.